Oxford Biomedica Plc (OXB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 529 | 2,322 | -3,074 | -1,880 | -107 |
| Other Working Capital | -4,847 | 5,438 | -8,072 | 20,916 | 2,389 |
| Other Operating Activity | -8,510 | -5,446 | -6,987 | -14,306 | -19,410 |
| Operating Cash Flow | $-12,828 | $2,314 | $-18,133 | $4,730 | $-17,128 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -555 | -287 | -918 | -414 | -215 |
| Net Acquisitions | N/A | N/A | N/A | 3,377 | N/A |
| Sale Of Investment | 36 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 13,206 | -3,751 | 15,597 | -5,118 | 4,440 |
| Investing Cash Flow | $12,687 | $-4,038 | $14,679 | $-2,155 | $4,225 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 210 | 396 | 611 | 345 | 629 |
| Other Financing Activity | -216 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-6 | $396 | $611 | $345 | $629 |
| Exchange Rate Effect | -2 | -11 | 22 | -1 | N/A |
| Beginning Cash Position | 6,802 | 8,141 | 10,962 | 8,043 | 20,317 |
| End Cash Position | 6,653 | 6,802 | 8,141 | 10,962 | 8,043 |
| Net Cash Flow | $-147 | $-1,328 | $-2,843 | $2,920 | $-12,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,828 | 2,314 | -18,133 | 4,730 | -17,128 |
| Capital Expenditure | -557 | -288 | -928 | -421 | -216 |
| Free Cash Flow | -13,385 | 2,026 | -19,061 | 4,309 | -17,344 |